BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nieberler M, Reuning U, Reichart F, Notni J, Wester HJ, Schwaiger M, Weinmüller M, Räder A, Steiger K, Kessler H. Exploring the Role of RGD-Recognizing Integrins in Cancer. Cancers (Basel) 2017;9:E116. [PMID: 28869579 DOI: 10.3390/cancers9090116] [Cited by in Crossref: 186] [Cited by in F6Publishing: 156] [Article Influence: 37.2] [Reference Citation Analysis]
Number Citing Articles
1 Baiula M, Cirillo M, Martelli G, Giraldi V, Gasparini E, Anelli AC, Spampinato SM, Giacomini D. Selective Integrin Ligands Promote Cell Internalization of the Antineoplastic Agent Fluorouracil. ACS Pharmacol Transl Sci 2021;4:1528-42. [PMID: 34661072 DOI: 10.1021/acsptsci.1c00094] [Reference Citation Analysis]
2 Zhu Z, Hou Q, Li M, Fu X. Molecular mechanism of myofibroblast formation and strategies for clinical drugs treatments in hypertrophic scars. J Cell Physiol 2020;235:4109-19. [PMID: 31612497 DOI: 10.1002/jcp.29302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Kadkhoda J, Tarighatnia A, Tohidkia MR, Nader ND, Aghanejad A. Photothermal therapy-mediated autophagy in breast cancer treatment: Progress and trends. Life Sciences 2022;298:120499. [DOI: 10.1016/j.lfs.2022.120499] [Reference Citation Analysis]
4 Moreira AM, Pereira J, Melo S, Fernandes MS, Carneiro P, Seruca R, Figueiredo J. The Extracellular Matrix: An Accomplice in Gastric Cancer Development and Progression. Cells 2020;9:E394. [PMID: 32046329 DOI: 10.3390/cells9020394] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
5 Hajipour H, Nouri M, Ghorbani M, Bahramifar A, Emameh RZ, Taheri RA. Targeted nanostructured lipid carrier containing galangin as a promising adjuvant for improving cytotoxic effects of chemotherapeutic agents. Naunyn Schmiedebergs Arch Pharmacol 2021. [PMID: 34522984 DOI: 10.1007/s00210-021-02152-9] [Reference Citation Analysis]
6 Fersing C, Bouhlel A, Cantelli C, Garrigue P, Lisowski V, Guillet B. A Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [18F]fluoride: Will [18F]AlF Replace 68Ga for Metal Chelate Labeling? Molecules 2019;24:E2866. [PMID: 31394799 DOI: 10.3390/molecules24162866] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
7 Räder AFB, Weinmüller M, Reichart F, Schumacher-klinger A, Merzbach S, Gilon C, Hoffman A, Kessler H. Orally Active Peptides: Is There a Magic Bullet? Angew Chem Int Ed 2018;57:14414-38. [DOI: 10.1002/anie.201807298] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 13.8] [Reference Citation Analysis]
8 Di leva FS, Tomassi S, Di maro S, Reichart F, Notni J, Dangi A, Marelli UK, Brancaccio D, Merlino F, Wester H, Novellino E, Kessler H, Marinelli L. Von einer Helix zu einem kleinen Ring: Metadynamik-inspirierte, selektive Liganden für αvβ6-Integrin. Angew Chem 2018;130:14856-60. [DOI: 10.1002/ange.201803250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
9 Clawson ML, Schuller G, Dickey AM, Bono JL, Murray RW, Sweeney MT, Apley MD, DeDonder KD, Capik SF, Larson RL, Lubbers BV, White BJ, Blom J, Chitko-McKown CG, Brichta-Harhay DM, Smith TPL. Differences between predicted outer membrane proteins of genotype 1 and 2 Mannheimia haemolytica. BMC Microbiol 2020;20:250. [PMID: 32787780 DOI: 10.1186/s12866-020-01932-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Zhang J, Zhang P, Zou Q, Li X, Fu J, Luo Y, Liang X, Jin Y. Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment. Molecules 2018;23:E2906. [PMID: 30405089 DOI: 10.3390/molecules23112906] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
11 Wang C, Zhang S, Liu J, Tian Y, Ma B, Xu S, Fu Y, Luo Y. Secreted Pyruvate Kinase M2 Promotes Lung Cancer Metastasis through Activating the Integrin Beta1/FAK Signaling Pathway. Cell Rep 2020;30:1780-1797.e6. [PMID: 32049010 DOI: 10.1016/j.celrep.2020.01.037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
12 Chen H, Luo Q, Wang J, He H, Luo W, Zhang L, Xiao Q, Chen T, Xu X, Niu W, Ke Y, Wang Y. Response of pH-Sensitive Doxorubicin Nanoparticles on Complex Tumor Microenvironments by Tailoring Multiple Physicochemical Properties. ACS Appl Mater Interfaces 2020;12:22673-86. [PMID: 32337980 DOI: 10.1021/acsami.0c05724] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Schneider H, Englert S, Macarrón Palacios A, Lerma Romero JA, Ali A, Avrutina O, Kolmar H. Synthetic Integrin-Targeting Dextran-Fc Hybrids Efficiently Inhibit Tumor Proliferation In Vitro. Front Chem 2021;9:693097. [PMID: 34368077 DOI: 10.3389/fchem.2021.693097] [Reference Citation Analysis]
14 Schönthal AH, Swenson SD, Chen TC, Markland FS. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review. Biochem Pharmacol 2020;181:114149. [PMID: 32663453 DOI: 10.1016/j.bcp.2020.114149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhu YS, Tang K, Lv J. Peptide-drug conjugate-based novel molecular drug delivery system in cancer. Trends Pharmacol Sci 2021:S0165-6147(21)00136-X. [PMID: 34334251 DOI: 10.1016/j.tips.2021.07.001] [Reference Citation Analysis]
16 Clausen MM, Carlsen EA, Christensen C, Madsen J, Brandt-larsen M, Klausen TL, Holm S, Loft A, Berthelsen AK, Kroman N, Knigge U, Kjaer A. First-in-Human Study of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET for Integrin αvβ3 Imaging in Patients with Breast Cancer and Neuroendocrine Neoplasms: Safety, Dosimetry and Tumor Imaging Ability. Diagnostics 2022;12:851. [DOI: 10.3390/diagnostics12040851] [Reference Citation Analysis]
17 Bauer A, Puglisi M, Nagl D, Schick JA, Werner T, Klingl A, El Andari J, Hornung V, Kessler H, Götz M, Grimm D, Brack-Werner R. Molecular Signature of Astrocytes for Gene Delivery by the Synthetic Adeno-Associated Viral Vector rAAV9P1. Adv Sci (Weinh) 2022;9:e2104979. [PMID: 35398994 DOI: 10.1002/advs.202104979] [Reference Citation Analysis]
18 Górski A, Międzybrodzki R, Jończyk-Matysiak E, Weber-Dąbrowska B, Bagińska N, Borysowski J. Perspectives of Phage-Eukaryotic Cell Interactions to Control Epstein-Barr Virus Infections. Front Microbiol 2018;9:630. [PMID: 29666617 DOI: 10.3389/fmicb.2018.00630] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Färber SF, Wurzer A, Reichart F, Beck R, Kessler H, Wester HJ, Notni J. Therapeutic Radiopharmaceuticals Targeting Integrin αvβ6. ACS Omega 2018;3:2428-36. [PMID: 30023833 DOI: 10.1021/acsomega.8b00035] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
20 Picheth GF, Ganzella FAO, Filizzola JO, Canquerino YK, Cardoso GC, Collini MB, Colauto LB, Figueroa-Magalhães MC, Cavalieri EA, Klassen G. Ligand-mediated nanomedicines against breast cancer: a review. Nanomedicine (Lond) 2022. [PMID: 35438008 DOI: 10.2217/nnm-2021-0473] [Reference Citation Analysis]
21 Novy Z, Stepankova J, Hola M, Flasarova D, Popper M, Petrik M. Preclinical Evaluation of Radiolabeled Peptides for PET Imaging of Glioblastoma Multiforme. Molecules 2019;24:E2496. [PMID: 31288488 DOI: 10.3390/molecules24132496] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
22 Xu X, Liu C, Wang Y, Koivisto O, Zhou J, Shu Y, Zhang H. Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment. Adv Drug Deliv Rev 2021;176:113891. [PMID: 34324887 DOI: 10.1016/j.addr.2021.113891] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
23 Deng Z, Chai J, Zeng Q, Zhang B, Ye T, Chen X, Xu X. The anticancer properties and mechanism of action of tablysin-15, the RGD-containing disintegrin, in breast cancer cells. Int J Biol Macromol 2019;129:1155-67. [PMID: 30660566 DOI: 10.1016/j.ijbiomac.2019.01.073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Yu T, Nie W, Hong Z, He Y, Chen J, Mi X, Yang S, Li X, Wang B, Lin Y, Gao X. Synergy of Immunostimulatory Genetherapy with Immune Checkpoint Blockade Motivates Immune Response to Eliminate Cancer. Adv Funct Mater 2021;31:2100715. [DOI: 10.1002/adfm.202100715] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
25 Muhammad N, Zhao H, Song W, Gu M, Li Q, Liu Y, Li C, Wang J, Zhan H. Silver nanoparticles functionalized Paclitaxel nanocrystals enhance overall anti-cancer effect on human cancer cells. Nanotechnology 2021;32:085105. [DOI: 10.1088/1361-6528/abcacb] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-β signal transduction for fibrosis and cancer therapy. Mol Cancer 2022;21. [DOI: 10.1186/s12943-022-01569-x] [Reference Citation Analysis]
27 Nieberler M, Reuning U, Kessler H, Reichart F, Weirich G, Wolff KD. Fluorescence imaging of invasive head and neck carcinoma cells with integrin αvβ6-targeting RGD-peptides: an approach to a fluorescence-assisted intraoperative cytological assessment of bony resection margins. Br J Oral Maxillofac Surg 2018;56:972-8. [PMID: 30502043 DOI: 10.1016/j.bjoms.2018.11.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
28 Arias-Mejias SM, Warda KY, Quattrocchi E, Alonso-Quinones H, Sominidi-Damodaran S, Meves A. The role of integrins in melanoma: a review. Int J Dermatol 2020;59:525-34. [PMID: 32157692 DOI: 10.1111/ijd.14850] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
29 Nardelli F, Ghitti M, Quilici G, Gori A, Luo Q, Berardi A, Sacchi A, Monieri M, Bergamaschi G, Bermel W, Chen F, Corti A, Curnis F, Musco G. A stapled chromogranin A-derived peptide is a potent dual ligand for integrins αvβ6 and αvβ8. Chem Commun (Camb) 2019;55:14777-80. [PMID: 31755501 DOI: 10.1039/c9cc08518a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Panzeri S, Arosio D, Gazzola S, Belvisi L, Civera M, Potenza D, Vasile F, Kemker I, Ertl T, Sewald N, Reiser O, Piarulli U. Cyclic RGD and isoDGR Integrin Ligands Containing cis-2-amino-1-cyclopentanecarboxylic (cis-β-ACPC) Scaffolds. Molecules 2020;25:E5966. [PMID: 33339382 DOI: 10.3390/molecules25245966] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Wang X, Luo D, Basilion JP. Photodynamic Therapy: Targeting Cancer Biomarkers for the Treatment of Cancers. Cancers (Basel) 2021;13:2992. [PMID: 34203805 DOI: 10.3390/cancers13122992] [Reference Citation Analysis]
32 Berillo D, Yeskendir A, Zharkinbekov Z, Raziyeva K, Saparov A. Peptide-Based Drug Delivery Systems. Medicina (Kaunas) 2021;57:1209. [PMID: 34833427 DOI: 10.3390/medicina57111209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
33 Zocchi MR, Tosetti F, Benelli R, Poggi A. Cancer Nanomedicine Special Issue Review Anticancer Drug Delivery with Nanoparticles: Extracellular Vesicles or Synthetic Nanobeads as Therapeutic Tools for Conventional Treatment or Immunotherapy. Cancers (Basel) 2020;12:E1886. [PMID: 32668783 DOI: 10.3390/cancers12071886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
34 De Las Rivas J, Brozovic A, Izraely S, Casas-Pais A, Witz IP, Figueroa A. Cancer drug resistance induced by EMT: novel therapeutic strategies. Arch Toxicol 2021;95:2279-97. [PMID: 34003341 DOI: 10.1007/s00204-021-03063-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Kang S, Lee S, Park S. iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery. Polymers (Basel) 2020;12:E1906. [PMID: 32847045 DOI: 10.3390/polym12091906] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
36 Farina B, Andrea C, Del Gatto A, Comegna D, Di Gaetano S, Capasso D, Paladino A, Acconcia C, Teresa Gentile M, Saviano M, Fattorusso R, Zaccaro L, Russo L. A novel approach for studying receptor-ligand interactions on living cells surface by using NUS/T1ρ-NMR methodologies combined with computational techniques: The RGDechi15D-αvβ5 integrin complex. Comput Struct Biotechnol J 2021;19:3303-18. [PMID: 34188779 DOI: 10.1016/j.csbj.2021.05.047] [Reference Citation Analysis]
37 Hou J, Yan D, Liu Y, Huang P, Cui H. The Roles of Integrin α5β1 in Human Cancer. Onco Targets Ther 2020;13:13329-44. [PMID: 33408483 DOI: 10.2147/OTT.S273803] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
38 Zoppi N, Chiarelli N, Ritelli M, Colombi M. Multifaced Roles of the αvβ3 Integrin in Ehlers-Danlos and Arterial Tortuosity Syndromes' Dermal Fibroblasts. Int J Mol Sci 2018;19:E982. [PMID: 29587413 DOI: 10.3390/ijms19040982] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
39 Chen J, Yang Q, Liu M, Lin M, Wang T, Zhang Z, Zhong X, Guo N, Lu Y, Xu J, Wang C, Han M, Wei Q. Remarkable Boron Delivery Of iRGD-Modified Polymeric Nanoparticles For Boron Neutron Capture Therapy. Int J Nanomedicine 2019;14:8161-77. [PMID: 31632025 DOI: 10.2147/IJN.S214224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
40 Qiao R, Xiao R, Chen Z, Jiang J, Yuan C, Ning S, Wang J, Zhou Z. Cloning, Expression and Inhibitory Effects on Lewis Lung Carcinoma Cells of rAj-Tspin from Sea Cucumber (Apostichopus japonicus). Molecules 2021;27:229. [PMID: 35011462 DOI: 10.3390/molecules27010229] [Reference Citation Analysis]
41 Mainini F, De Santis F, Fucà G, Di Nicola M, Rivoltini L, Eccles M. Nanobiotechnology and Immunotherapy: Two Powerful and Cooperative Allies against Cancer. Cancers (Basel) 2021;13:3765. [PMID: 34359665 DOI: 10.3390/cancers13153765] [Reference Citation Analysis]
42 Soejima Y, Takeuchi M, Miyamoto N, Sawabe M, Fukusato T. ITGB6-Knockout Suppresses Cholangiocarcinoma Cell Migration and Invasion with Declining PODXL2 Expression. Int J Mol Sci 2021;22:6303. [PMID: 34208313 DOI: 10.3390/ijms22126303] [Reference Citation Analysis]
43 Ludwig BS, Kessler H, Kossatz S, Reuning U. RGD-Binding Integrins Revisited: How Recently Discovered Functions and Novel Synthetic Ligands (Re-)Shape an Ever-Evolving Field. Cancers (Basel) 2021;13:1711. [PMID: 33916607 DOI: 10.3390/cancers13071711] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
44 Zhang N, Xu Y, Xin X, Huo P, Zhang Y, Chen H, Feng N, Feng Q, Zhang Z. Dual-modal imaging-guided theranostic nanocarriers based on 2-methoxyestradiol and indocyanine green. Int J Pharm 2021;592:120098. [PMID: 33220381 DOI: 10.1016/j.ijpharm.2020.120098] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Paulus J, Sewald N. Synthesis and Evaluation of a Non-Peptide Small-Molecule Drug Conjugate Targeting Integrin αVβ3. Front Chem 2022;10:869639. [DOI: 10.3389/fchem.2022.869639] [Reference Citation Analysis]
46 Ludwig BS, Tomassi S, Di Maro S, Di Leva FS, Benge A, Reichart F, Nieberler M, Kühn FE, Kessler H, Marinelli L, Reuning U, Kossatz S. The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrins. Biomaterials 2021;271:120754. [PMID: 33756215 DOI: 10.1016/j.biomaterials.2021.120754] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
47 Hamdan F, Bigdeli Z, Asghari SM, Sadremomtaz A, Balalaie S. Synthesis of Modified RGD-Based Peptides and Their in vitro Activity. ChemMedChem 2019;14:282-8. [PMID: 30506622 DOI: 10.1002/cmdc.201800704] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
48 Wu PH, Opadele AE, Onodera Y, Nam JM. Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy. Cancers (Basel) 2019;11:E1783. [PMID: 31766201 DOI: 10.3390/cancers11111783] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 9.7] [Reference Citation Analysis]
49 Rivera-Soto R, Dissinger NJ, Damania B. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3. J Virol 2020;94:e01384-19. [PMID: 31801855 DOI: 10.1128/JVI.01384-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
50 Ni JH, Yang WX. Extracellular and Intracellular Skeletons: How Do They Involve in Apoptosis. DNA Cell Biol 2021. [PMID: 34847739 DOI: 10.1089/dna.2021.0613] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Simón-Gracia L, Hunt H, Teesalu T. Peritoneal Carcinomatosis Targeting with Tumor Homing Peptides. Molecules 2018;23:E1190. [PMID: 29772690 DOI: 10.3390/molecules23051190] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
52 Attia MF, Swasy MI, Akasov R, Alexis F, Whitehead DC. Strategies for High Grafting Efficiency of Functional Ligands to Lipid Nanoemulsions for RGD-Mediated Targeting of Tumor Cells In Vitro. ACS Appl Bio Mater 2020;3:5067-79. [DOI: 10.1021/acsabm.0c00567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Tomassi S, D'Amore VM, Di Leva FS, Vannini A, Quilici G, Weinmüller M, Reichart F, Amato J, Romano B, Izzo AA, Di Maro S, Novellino E, Musco G, Gianni T, Kessler H, Marinelli L. Halting the Spread of Herpes Simplex Virus-1: The Discovery of an Effective Dual αvβ6/αvβ8 Integrin Ligand. J Med Chem 2021;64:6972-84. [PMID: 33961417 DOI: 10.1021/acs.jmedchem.1c00533] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Miller CL, Sagiv-Barfi I, Neuhöfer P, Czerwinski DK, Artandi SE, Bertozzi CR, Levy R, Cochran JR. Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression. Cell Chem Biol 2021:S2451-9456(21)00476-1. [PMID: 34774126 DOI: 10.1016/j.chembiol.2021.10.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Jwad R, Weissberger D, Hunter L. Strategies for Fine-Tuning the Conformations of Cyclic Peptides. Chem Rev 2020;120:9743-89. [PMID: 32786420 DOI: 10.1021/acs.chemrev.0c00013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
56 Sachindra S, Hellberg T, Exner S, Prasad S, Beindorff N, Rogalla S, Kimura R, Gambhir SS, Wiedenmann B, Grötzinger C. SPECT/CT Imaging, Biodistribution and Radiation Dosimetry of a 177Lu-DOTA-Integrin αvβ6 Cystine Knot Peptide in a Pancreatic Cancer Xenograft Model. Front Oncol 2021;11:684713. [PMID: 34136410 DOI: 10.3389/fonc.2021.684713] [Reference Citation Analysis]
57 Fu D, Huang X, Lv Z, Zhang Y, Chen M, Zhang W, Su D. Ultrasound and magnetic resonance imaging of cyclic arginine glycine aspartic acid-gadopentetic acid-polylactic acid in human breast cancer by targeting αvβ3 in xenograft-bearing nude mice. Bioengineered 2022;13:7105-17. [PMID: 35259049 DOI: 10.1080/21655979.2022.2045832] [Reference Citation Analysis]
58 Lo WL, Lo SW, Chen SJ, Chen MW, Huang YR, Chen LC, Chang CH, Li MH. Molecular Imaging and Preclinical Studies of Radiolabeled Long-Term RGD Peptides in U-87 MG Tumor-Bearing Mice. Int J Mol Sci 2021;22:5459. [PMID: 34064291 DOI: 10.3390/ijms22115459] [Reference Citation Analysis]
59 Vannini A, Leoni V, Barboni C, Sanapo M, Zaghini A, Malatesta P, Campadelli-Fiume G, Gianni T. αvβ3-integrin regulates PD-L1 expression and is involved in cancer immune evasion. Proc Natl Acad Sci U S A 2019;116:20141-50. [PMID: 31527243 DOI: 10.1073/pnas.1901931116] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
60 Polo E, Nitka TT, Neubert E, Erpenbeck L, Vuković L, Kruss S. Control of Integrin Affinity by Confining RGD Peptides on Fluorescent Carbon Nanotubes. ACS Appl Mater Interfaces 2018;10:17693-703. [DOI: 10.1021/acsami.8b04373] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 6.8] [Reference Citation Analysis]
61 Quigley NG, Steiger K, Hoberück S, Czech N, Zierke MA, Kossatz S, Pretze M, Richter F, Weichert W, Pox C, Kotzerke J, Notni J. PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin. Eur J Nucl Med Mol Imaging 2021. [PMID: 34559266 DOI: 10.1007/s00259-021-05559-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Kossatz S, Beer AJ, Notni J. It's Time to Shift the Paradigm: Translation and Clinical Application of Non-αvβ3 Integrin Targeting Radiopharmaceuticals. Cancers (Basel) 2021;13:5958. [PMID: 34885066 DOI: 10.3390/cancers13235958] [Reference Citation Analysis]
63 Reichart F, Maltsev OV, Kapp TG, Räder AFB, Weinmüller M, Marelli UK, Notni J, Wurzer A, Beck R, Wester H, Steiger K, Di Maro S, Di Leva FS, Marinelli L, Nieberler M, Reuning U, Schwaiger M, Kessler H. Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic Peptide. J Med Chem 2019;62:2024-37. [DOI: 10.1021/acs.jmedchem.8b01588] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
64 Kim Y, Laradji AM, Sharma S, Zhang W, Yadavalli NS, Xie J, Popik V, Minko S. Refining of Particulates at Stimuli-Responsive Interfaces: Label-Free Sorting and Isolation. Angew Chem Int Ed Engl 2021;:e202110990. [PMID: 34841648 DOI: 10.1002/anie.202110990] [Reference Citation Analysis]
65 Li X, Jian M, Sun Y, Zhu Q, Wang Z. The Peptide Functionalized Inorganic Nanoparticles for Cancer-Related Bioanalytical and Biomedical Applications. Molecules 2021;26:3228. [PMID: 34072160 DOI: 10.3390/molecules26113228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Martelli G, Baiula M, Caligiana A, Galletti P, Gentilucci L, Artali R, Spampinato S, Giacomini D. Could Dissecting the Molecular Framework of β-Lactam Integrin Ligands Enhance Selectivity? J Med Chem 2019;62:10156-66. [DOI: 10.1021/acs.jmedchem.9b01000] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
67 Sani S, Messe M, Fuchs Q, Pierrevelcin M, Laquerriere P, Entz-Werle N, Reita D, Etienne-Selloum N, Bruban V, Choulier L, Martin S, Dontenwill M. Biological Relevance of RGD-Integrin Subtype-Specific Ligands in Cancer. Chembiochem 2021;22:1151-60. [PMID: 33140906 DOI: 10.1002/cbic.202000626] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
68 Feni L, Parente S, Robert C, Gazzola S, Arosio D, Piarulli U, Neundorf I. Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide. Bioconjug Chem 2019;30:2011-22. [PMID: 31243977 DOI: 10.1021/acs.bioconjchem.9b00292] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
69 Loret EP, Luis J, Nuccio C, Villard C, Mansuelle P, Lebrun R, Villard PH. A Low Molecular Weight Protein from the Sea Anemone Anemonia viridis with an Anti-Angiogenic Activity. Mar Drugs 2018;16:E134. [PMID: 29671760 DOI: 10.3390/md16040134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
70 Dolinschek R, Hingerl J, Benge A, Zafiu C, Schüren E, Ehmoser EK, Lössner D, Reuning U. Constitutive activation of integrin αvβ3 contributes to anoikis resistance of ovarian cancer cells. Mol Oncol 2021;15:503-22. [PMID: 33155399 DOI: 10.1002/1878-0261.12845] [Reference Citation Analysis]
71 Nery de Albuquerque Rego G, da Hora Alves A, Penteado Nucci M, Bustamante Mamani J, Anselmo de Oliveira F, Gamarra LF. Antiangiogenic Targets for Glioblastoma Therapy from a Pre-Clinical Approach, Using Nanoformulations. Int J Mol Sci 2020;21:E4490. [PMID: 32599834 DOI: 10.3390/ijms21124490] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
72 Frickenstein AN, Hagood JM, Britten CN, Abbott BS, McNally MW, Vopat CA, Patterson EG, MacCuaig WM, Jain A, Walters KB, McNally LR. Mesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect. Pharmaceutics 2021;13:570. [PMID: 33920503 DOI: 10.3390/pharmaceutics13040570] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
73 Zietek T, Boomgaarden WAD, Rath E. Drug Screening, Oral Bioavailability and Regulatory Aspects: A Need for Human Organoids. Pharmaceutics 2021;13:1280. [PMID: 34452240 DOI: 10.3390/pharmaceutics13081280] [Reference Citation Analysis]
74 Cruz da Silva E, Dontenwill M, Choulier L, Lehmann M. Role of Integrins in Resistance to Therapies Targeting Growth Factor Receptors in Cancer. Cancers (Basel) 2019;11:E692. [PMID: 31109009 DOI: 10.3390/cancers11050692] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
75 Gower-Fry L, Kronemann T, Dorian A, Pu Y, Jaworski C, Wängler C, Bartenstein P, Beyer L, Lindner S, Jurkschat K, Wängler B, Bailey JJ, Schirrmacher R. Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) 18F-Radiopharmaceuticals. Pharmaceuticals (Basel) 2021;14:701. [PMID: 34358127 DOI: 10.3390/ph14070701] [Reference Citation Analysis]
76 Sun S, Ding Z, Yang X, Zhao X, Zhao M, Gao L, Chen Q, Xie S, Liu A, Yin S, Xu Z, Lu X. Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy. Int J Nanomedicine 2021;16:2337-56. [PMID: 33790553 DOI: 10.2147/IJN.S297631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
77 Li X, Zhou X, Liu J, Zhang J, Feng Y, Wang F, He Y, Wan A, Filipczak N, Yalamarty SSK, Jin Y, Torchilin VP. Liposomal Co-delivery of PD-L1 siRNA/Anemoside B4 for Enhanced Combinational Immunotherapeutic Effect. ACS Appl Mater Interfaces 2022. [PMID: 35726706 DOI: 10.1021/acsami.2c01123] [Reference Citation Analysis]
78 Rangger C, Haubner R. Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology. Pharmaceuticals (Basel) 2020;13:E22. [PMID: 32019275 DOI: 10.3390/ph13020022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
79 Kondo N, Wakamori K, Hirata M, Temma T. Radioiodinated bicyclic RGD peptide for imaging integrin αvβ3 in cancers. Biochem Biophys Res Commun 2020;528:168-73. [PMID: 32451087 DOI: 10.1016/j.bbrc.2020.05.106] [Reference Citation Analysis]
80 Anselmi M, Borbély A, Figueras E, Michalek C, Kemker I, Gentilucci L, Sewald N. Linker Hydrophilicity Modulates the Anticancer Activity of RGD-Cryptophycin Conjugates. Chemistry 2021;27:1015-22. [PMID: 32955139 DOI: 10.1002/chem.202003471] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Weiler SME, Lutz T, Bissinger M, Sticht C, Knaub M, Gretz N, Schirmacher P, Breuhahn K. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells. Cancer Lett 2020;473:164-75. [PMID: 31904487 DOI: 10.1016/j.canlet.2019.12.044] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
82 Luo Q, Tao Y, Sheng W, Lu J, Wang H. Dinitroimidazoles as bifunctional bioconjugation reagents for protein functionalization and peptide macrocyclization. Nat Commun 2019;10:142. [PMID: 30635561 DOI: 10.1038/s41467-018-08010-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
83 Gayraud F, Klußmann M, Neundorf I. Recent Advances and Trends in Chemical CPP-Drug Conjugation Techniques. Molecules 2021;26:1591. [PMID: 33805680 DOI: 10.3390/molecules26061591] [Reference Citation Analysis]
84 Park SE, El-Sayed NS, Shamloo K, Lohan S, Kumar S, Sajid MI, Tiwari RK. Targeted Delivery of Cabazitaxel Using Cyclic Cell-Penetrating Peptide and Biomarkers of Extracellular Matrix for Prostate and Breast Cancer Therapy. Bioconjug Chem 2021. [PMID: 34309357 DOI: 10.1021/acs.bioconjchem.1c00319] [Reference Citation Analysis]
85 Han J, Sun J, Song S, Beljaars L, Groothuis GMM, Permentier H, Bischoff R, Halmos GB, Verhoeven CJ, Amstalden van Hove ER, Horvatovich P, Casini A. Targeted imaging of integrins in cancer tissues using photocleavable Ru(ii) polypyridine complexes as mass-tags. Chem Commun (Camb) 2020;56:5941-4. [PMID: 32347235 DOI: 10.1039/d0cc00774a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
86 Dehghani-ghobadi Z, Sheikh Hasani S, Arefian E, Hossein G. Wnt5A and TGFβ1 Converges through YAP1 Activity and Integrin Alpha v Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation. Cells 2022;11:237. [DOI: 10.3390/cells11020237] [Reference Citation Analysis]
87 Di leva FS, Tomassi S, Di maro S, Reichart F, Notni J, Dangi A, Marelli UK, Brancaccio D, Merlino F, Wester H, Novellino E, Kessler H, Marinelli L. From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands. Angew Chem Int Ed 2018;57:14645-9. [DOI: 10.1002/anie.201803250] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
88 Jia Q, Zhang X, Zhang A, Wu R, Liu Z, Chen Y, Wang J, Lv L. rLj-RGD4, the shortened peptide of rLj-RGD3 from Lampetra japonica, protects against cerebral ischemia/reperfusion injury via the PI3K/Akt pathway. Peptides 2020;129:170310. [PMID: 32389578 DOI: 10.1016/j.peptides.2020.170310] [Reference Citation Analysis]
89 Shao J, Liang R, Ding D, Zheng X, Zhu X, Hu S, Wei H, Wei B. A Smart Multifunctional Nanoparticle for Enhanced Near-Infrared Image-Guided Photothermal Therapy Against Gastric Cancer. Int J Nanomedicine 2021;16:2897-915. [PMID: 33907399 DOI: 10.2147/IJN.S289310] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
90 Rocha LA, Learmonth DA, Sousa RA, Salgado AJ. αvβ3 and α5β1 integrin-specific ligands: From tumor angiogenesis inhibitors to vascularization promoters in regenerative medicine? Biotechnol Adv 2018;36:208-27. [PMID: 29155160 DOI: 10.1016/j.biotechadv.2017.11.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
91 Duosiken D, Yang R, Dai Y, Marfavi Z, Lv Q, Li H, Sun K, Tao K. Near-Infrared Light-Excited Reactive Oxygen Species Generation by Thulium Oxide Nanoparticles. J Am Chem Soc 2022. [PMID: 35118859 DOI: 10.1021/jacs.1c11704] [Reference Citation Analysis]
92 Kanyo N, Kovacs KD, Saftics A, Szekacs I, Peter B, Santa-Maria AR, Walter FR, Dér A, Deli MA, Horvath R. Glycocalyx regulates the strength and kinetics of cancer cell adhesion revealed by biophysical models based on high resolution label-free optical data. Sci Rep 2020;10:22422. [PMID: 33380731 DOI: 10.1038/s41598-020-80033-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
93 Viale M, Tosto R, Giglio V, Pappalardo G, Oliveri V, Maric I, Mariggiò MA, Vecchio G. Cyclodextrin polymers decorated with RGD peptide as delivery systems for targeted anti-cancer chemotherapy. Invest New Drugs 2019;37:771-8. [PMID: 30556100 DOI: 10.1007/s10637-018-0711-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
94 Cui J, Yue JB. Current status and advances in arginine‐glycine‐aspartic acid peptide‐based molecular imaging to evaluate the effects of anti‐angiogenic therapies. Prec Radiat Oncol 2019;3:29-34. [DOI: 10.1002/pro6.60] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
95 Li D, Shi M, Bao C, Bao W, Zhang L, Jiao L, Li T, Li Y. Synergistically enhanced anticancer effect of codelivered curcumin and siPlk1 by stimuli-responsive α-lactalbumin nanospheres. Nanomedicine (Lond) 2019;14:595-612. [PMID: 30806584 DOI: 10.2217/nnm-2018-0291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
96 Rastegari E, Hsiao YJ, Lai WY, Lai YH, Yang TC, Chen SJ, Huang PI, Chiou SH, Mou CY, Chien Y. An Update on Mesoporous Silica Nanoparticle Applications in Nanomedicine. Pharmaceutics 2021;13:1067. [PMID: 34371758 DOI: 10.3390/pharmaceutics13071067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
97 Cirillo M, Giacomini D. Molecular Delivery of Cytotoxic Agents via Integrin Activation. Cancers (Basel) 2021;13:299. [PMID: 33467465 DOI: 10.3390/cancers13020299] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Vucko T, Pétry N, Dehez F, Lambert A, Monari A, Lakomy C, Lacolley P, Regnault V, Collet C, Karcher G, Pellegrini-moïse N, Lamandé-langle S. C-glyco“RGD” as αIIbβ3 and αvβ integrin ligands for imaging applications: Synthesis, in vitro evaluation and molecular modeling. Bioorganic & Medicinal Chemistry 2019;27:4101-9. [DOI: 10.1016/j.bmc.2019.07.039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
99 Chia JY, Miki T, Mihara H, Tsutsumi H. Biofunctional supramolecular hydrogels fabricated from a short self-assembling peptide modified with bioactive sequences for the 3D culture of breast cancer MCF-7 cells. Bioorg Med Chem 2021;46:116345. [PMID: 34416510 DOI: 10.1016/j.bmc.2021.116345] [Reference Citation Analysis]
100 Mizuno Y, Kimura K, Onoe S, Shukuri M, Kuge Y, Akizawa H. Influence of Linker Molecules in Hexavalent RGD Peptides on Their Multivalent Interactions with Integrin αvβ3. J Med Chem 2021;64:16008-19. [PMID: 34730982 DOI: 10.1021/acs.jmedchem.1c01396] [Reference Citation Analysis]
101 Jamhiri I, Zahri S, Mehrabani D, Khodabandeh Z, Dianatpour M, Yaghobi R, Hosseini SY. Enhancing the apoptotic effect of IL-24/mda-7 on the human hepatic stellate cell through RGD peptide modification. Immunological Investigations 2018;47:335-50. [DOI: 10.1080/08820139.2018.1433202] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
102 Middleton JD, Sivakumar S, Hai T. Chemotherapy-Induced Changes in the Lung Microenvironment: The Role of MMP-2 in Facilitating Intravascular Arrest of Breast Cancer Cells. Int J Mol Sci 2021;22:10280. [PMID: 34638621 DOI: 10.3390/ijms221910280] [Reference Citation Analysis]
103 Bledzka K, Qin J, Plow EF. Integrin αIIbβ3. Platelets. Elsevier; 2019. pp. 227-41. [DOI: 10.1016/b978-0-12-813456-6.00012-6] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
104 Krajcovicova S, Daniskova A, Bendova K, Novy Z, Soural M, Petrik M. [68Ga]Ga-DFO-c(RGDyK): Synthesis and Evaluation of Its Potential for Tumor Imaging in Mice. Int J Mol Sci 2021;22:7391. [PMID: 34299008 DOI: 10.3390/ijms22147391] [Reference Citation Analysis]
105 Zietek T, Giesbertz P, Ewers M, Reichart F, Weinmüller M, Urbauer E, Haller D, Demir IE, Ceyhan GO, Kessler H, Rath E. Organoids to Study Intestinal Nutrient Transport, Drug Uptake and Metabolism - Update to the Human Model and Expansion of Applications. Front Bioeng Biotechnol 2020;8:577656. [PMID: 33015026 DOI: 10.3389/fbioe.2020.577656] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
106 Wang F, Xu C, Peng R, Li B, Shen X, Zheng H, Lao X. Effect of a C-end rule modification on antitumor activity of thymosin α1. Biochimie 2018;154:99-106. [PMID: 30096371 DOI: 10.1016/j.biochi.2018.08.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
107 Tuguzbaeva G, Yue E, Chen X, He L, Li X, Ju J, Qin Y, Pavlov V, Lu Y, Jia W, Bai Y, Niu Y, Yang B. PEP06 polypeptide 30 is a novel cluster-dissociating agent inhibiting α v integrin/FAK/Src signaling in oral squamous cell carcinoma cells. Acta Pharm Sin B 2019;9:1163-73. [PMID: 31867162 DOI: 10.1016/j.apsb.2019.10.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
108 Li X, Zou Q, Zhang J, Zhang P, Zhou X, Yalamarty SSK, Liang X, Liu Y, Zheng Q, Gao J. Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer. Int J Nanomedicine 2020;15:6791-811. [PMID: 32982234 DOI: 10.2147/IJN.S260477] [Reference Citation Analysis]
109 Aass KR, Kastnes MH, Standal T. Molecular interactions and functions of IL-32. J Leukoc Biol 2021;109:143-59. [PMID: 32869391 DOI: 10.1002/JLB.3MR0620-550R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
110 Achilli S, Berthet N, Renaudet O. Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer. RSC Chem Biol 2021;2:713-24. [PMID: 34212148 DOI: 10.1039/d1cb00007a] [Reference Citation Analysis]
111 Vakhshiteh F, Khabazian E, Atyabi F, Ostad SN, Madjd Z, Dinarvand R. Peptide-conjugated liposomes for targeted miR-34a delivery to suppress breast cancer and cancer stem-like population. Journal of Drug Delivery Science and Technology 2020;57:101687. [DOI: 10.1016/j.jddst.2020.101687] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
112 Fujita M, Sasada M, Iyoda T, Fukai F. Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide.Molecules. 2020;25. [PMID: 32708610 DOI: 10.3390/molecules25143239] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
113 Merlino F, Daniele S, La Pietra V, Di Maro S, Di Leva FS, Brancaccio D, Tomassi S, Giuntini S, Cerofolini L, Fragai M, Luchinat C, Reichart F, Cavallini C, Costa B, Piccarducci R, Taliani S, Da Settimo F, Martini C, Kessler H, Novellino E, Marinelli L. Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme. J Med Chem 2018;61:4791-809. [PMID: 29775303 DOI: 10.1021/acs.jmedchem.8b00004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
114 Kapp TG, Di Leva FS, Notni J, Räder AFB, Fottner M, Reichart F, Reich D, Wurzer A, Steiger K, Novellino E, Marelli UK, Wester H, Marinelli L, Kessler H. N -Methylation of iso DGR Peptides: Discovery of a Selective α5β1-Integrin Ligand as a Potent Tumor Imaging Agent. J Med Chem 2018;61:2490-9. [DOI: 10.1021/acs.jmedchem.7b01752] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
115 Etienne-Selloum N, Prades J, Bello-Roufai D, Boone M, Sevestre H, Trudel S, Caillet P, Coutte A, Desenclos C, Constans JM, Martin S, Choulier L, Chauffert B, Dontenwill M. Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for Glioblastoma. Pharmaceuticals (Basel) 2021;14:882. [PMID: 34577582 DOI: 10.3390/ph14090882] [Reference Citation Analysis]
116 Gao S, Li T, Guo Y, Sun C, Xianyu B, Xu H. Selenium-Containing Nanoparticles Combine the NK Cells Mediated Immunotherapy with Radiotherapy and Chemotherapy. Adv Mater 2020;32:e1907568. [PMID: 32053267 DOI: 10.1002/adma.201907568] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 43.0] [Reference Citation Analysis]
117 Neves MI, Moroni L, Barrias CC. Modulating Alginate Hydrogels for Improved Biological Performance as Cellular 3D Microenvironments. Front Bioeng Biotechnol 2020;8:665. [PMID: 32695759 DOI: 10.3389/fbioe.2020.00665] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
118 Quaglia F, Krishn SR, Wang Y, Goodrich DW, McCue P, Kossenkov AV, Mandigo AC, Knudsen KE, Weinreb PH, Corey E, Kelly WK, Languino LR. Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progression. PLoS One 2021;16:e0244985. [PMID: 33481853 DOI: 10.1371/journal.pone.0244985] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
119 Sani S, Pallaoro N, Messe M, Bernhard C, Etienne-Selloum N, Kessler H, Marinelli L, Entz-Werle N, Foppolo S, Martin S, Reita D, Dontenwill M. Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin. Cancers (Basel) 2022;14:369. [PMID: 35053532 DOI: 10.3390/cancers14020369] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Judmann B, Braun D, Wängler B, Schirrmacher R, Fricker G, Wängler C. Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy. Pharmaceuticals (Basel) 2020;13:E173. [PMID: 32751666 DOI: 10.3390/ph13080173] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
121 Kim Y, Laradji AM, Sharma S, Zhang W, Yadavalli NS, Xie J, Popik V, Minko S. Refining of Particulates at Stimuli‐Responsive Interfaces: Label‐Free Sorting and Isolation. Angewandte Chemie. [DOI: 10.1002/ange.202110990] [Reference Citation Analysis]
122 Hehenberger E, Eitel M, Fortunato SAV, Miller DJ, Keeling PJ, Cahill MA. Early eukaryotic origins and metazoan elaboration of MAPR family proteins. Mol Phylogenet Evol 2020;148:106814. [PMID: 32278076 DOI: 10.1016/j.ympev.2020.106814] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
123 Hill BS, Sarnella A, Capasso D, Comegna D, Del Gatto A, Gramanzini M, Albanese S, Saviano M, Zaccaro L, Zannetti A. Therapeutic Potential of a Novel αvβ₃ Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type. Cancers (Basel) 2019;11:E139. [PMID: 30682838 DOI: 10.3390/cancers11020139] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
124 Park EJ, Myint PK, Ito A, Appiah MG, Darkwah S, Kawamoto E, Shimaoka M. Integrin-Ligand Interactions in Inflammation, Cancer, and Metabolic Disease: Insights Into the Multifaceted Roles of an Emerging Ligand Irisin. Front Cell Dev Biol 2020;8:588066. [PMID: 33195249 DOI: 10.3389/fcell.2020.588066] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
125 Kamal NAMA, Abdulmalek E, Fakurazi S, Cordova KE, Abdul Rahman MB. Surface peptide functionalization of zeolitic imidazolate framework-8 for autonomous homing and enhanced delivery of chemotherapeutic agent to lung tumor cells. Dalton Trans 2021;50:2375-86. [PMID: 33555001 DOI: 10.1039/d1dt00116g] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Ribeiro-Dias F, Oliveira IBN. A Critical Overview of Interleukin 32 in Leishmaniases. Front Immunol 2022;13:849340. [PMID: 35309341 DOI: 10.3389/fimmu.2022.849340] [Reference Citation Analysis]
127 Cheng TM, Chang WJ, Chu HY, De Luca R, Pedersen JZ, Incerpi S, Li ZL, Shih YJ, Lin HY, Wang K, Whang-Peng J. Nano-Strategies Targeting the Integrin αvβ3 Network for Cancer Therapy. Cells 2021;10:1684. [PMID: 34359854 DOI: 10.3390/cells10071684] [Reference Citation Analysis]
128 Erbaba B, Burhan ÖP, Şerifoğlu N, Muratoğlu B, Kahveci F, Adams MM, Arslan-Ergül A. Zebrafish brain RNA sequencing reveals that cell adhesion molecules are critical in brain aging. Neurobiol Aging 2020;94:164-75. [PMID: 32629311 DOI: 10.1016/j.neurobiolaging.2020.04.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
129 Schmohl KA, Nelson PJ, Spitzweg C. Tetrac as an anti-angiogenic agent in cancer. Endocr Relat Cancer 2019;26:R287-304. [PMID: 31063970 DOI: 10.1530/ERC-19-0058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
130 Ruvolo PP, Ruvolo VR, Burks JK, Qiu Y, Wang RY, Shpall EJ, Mirandola L, Hail N Jr, Zeng Z, McQueen T, Daver N, Post SM, Chiriva-Internati M, Kornblau SM, Andreeff M. Role of MSC-derived galectin 3 in the AML microenvironment. Biochim Biophys Acta Mol Cell Res 2018;1865:959-69. [PMID: 29655803 DOI: 10.1016/j.bbamcr.2018.04.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
131 Motealleh A, Kehr NS. Step‐Gradient Composite Hydrogels for Local Drug Delivery and Directed Cell Migration. Adv NanoBio Res 2021;1:2000114. [DOI: 10.1002/anbr.202000114] [Reference Citation Analysis]
132 Kim GC, Cheon DH, Lee Y. Challenge to overcome current limitations of cell-penetrating peptides. Biochim Biophys Acta Proteins Proteom 2021;1869:140604. [PMID: 33453413 DOI: 10.1016/j.bbapap.2021.140604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
133 Leonidis G, Dalezis P, Trafalis D, Beis D, Giardoglou P, Koukiali A, Sigala I, Nikolakaki E, Sarli V. Synthesis and Biological Evaluation of a c(RGDyK) Peptide Conjugate of SRPIN803. ACS Omega 2021;6:28379-93. [PMID: 34723035 DOI: 10.1021/acsomega.1c04576] [Reference Citation Analysis]
134 Lepsenyi M, Algethami N, Al-Haidari AA, Algaber A, Syk I, Rahman M, Thorlacius H. CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells. Clin Exp Metastasis 2021;38:401-10. [PMID: 34115261 DOI: 10.1007/s10585-021-10103-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Pokharel M, Park K. Light mediated drug delivery systems: a review. J Drug Target 2021;:1-13. [PMID: 34761711 DOI: 10.1080/1061186X.2021.2005610] [Reference Citation Analysis]
136 Gessner I, Neundorf I. Nanoparticles Modified with Cell-Penetrating Peptides: Conjugation Mechanisms, Physicochemical Properties, and Application in Cancer Diagnosis and Therapy. Int J Mol Sci 2020;21:E2536. [PMID: 32268473 DOI: 10.3390/ijms21072536] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 15.0] [Reference Citation Analysis]
137 Wang L, Chen H, Wang F, Zhang X. The development of peptide-drug conjugates (PDCs) strategies for paclitaxel. Expert Opin Drug Deliv 2022. [PMID: 35130795 DOI: 10.1080/17425247.2022.2039621] [Reference Citation Analysis]
138 Martínez-Jothar L, Barendrecht AD, de Graaff AM, Oliveira S, van Nostrum CF, Schiffelers RM, Hennink WE, Fens MHAM. Endothelial Cell Targeting by cRGD-Functionalized Polymeric Nanoparticles under Static and Flow Conditions. Nanomaterials (Basel) 2020;10:E1353. [PMID: 32664364 DOI: 10.3390/nano10071353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
139 Kemker I, Schröder DC, Feiner RC, Müller KM, Marion A, Sewald N. Tuning the Biological Activity of RGD Peptides with Halotryptophans†. J Med Chem 2021;64:586-601. [PMID: 33356253 DOI: 10.1021/acs.jmedchem.0c01536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Nikfar Z, Shariatinia Z. The RGD tripeptide anticancer drug carrier: DFT computations and molecular dynamics simulations. Journal of Molecular Liquids 2019;281:565-83. [DOI: 10.1016/j.molliq.2019.02.114] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 6.7] [Reference Citation Analysis]
141 Deng Z, Zeng Q, Chai J, Zhang B, Zheng W, Xu X, Wu J. Disintegrin Tablysin-15 Suppresses Cancer Hallmarks in Melanoma Cells by Blocking FAK/Akt/ERK and NF-κB Signaling. Curr Cancer Drug Targets 2020;20:306-15. [PMID: 31893992 DOI: 10.2174/1568009620666200101094736] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
142 Porubský M, Gurská S, Stanková J, Hajdúch M, Džubák P, Hlaváč J. AminoBODIPY Conjugates for Targeted Drug Delivery Systems and Real-Time Monitoring of Drug Release. Mol Pharm 2021;18:2385-96. [PMID: 33961440 DOI: 10.1021/acs.molpharmaceut.1c00219] [Reference Citation Analysis]
143 Wang HB, Yang J, Shuai W, Yang J, Liu LB, Xu M, Tang QZ. Deletion of Microfibrillar-Associated Protein 4 Attenuates Left Ventricular Remodeling and Dysfunction in Heart Failure. J Am Heart Assoc 2020;9:e015307. [PMID: 32856514 DOI: 10.1161/JAHA.119.015307] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
144 Ellert-Miklaszewska A, Poleszak K, Pasierbinska M, Kaminska B. Integrin Signaling in Glioma Pathogenesis: From Biology to Therapy. Int J Mol Sci 2020;21:E888. [PMID: 32019108 DOI: 10.3390/ijms21030888] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
145 Ghelman J, Grewing L, Windener F, Albrecht S, Zarbock A, Kuhlmann T. SKAP2 as a new regulator of oligodendroglial migration and myelin sheath formation. Glia 2021;69:2699-716. [PMID: 34324225 DOI: 10.1002/glia.24066] [Reference Citation Analysis]
146 Zhang X, van Rijt S. 2D biointerfaces to study stem cell-ligand interactions. Acta Biomater 2021;131:80-96. [PMID: 34237424 DOI: 10.1016/j.actbio.2021.06.044] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
147 Ghabraie E, Kemker I, Tonali N, Ismail M, Dodero VI, Sewald N. Phenothiazine-Biaryl-Containing Fluorescent RGD Peptides. Chemistry 2020;26:12036-42. [PMID: 32297686 DOI: 10.1002/chem.202001312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
148 Chen YC, Chang YT, Chen CY, Shiu JH, Cheng CH, Huang CH, Chen JF, Chuang WJ. Structural Insight into Integrin Recognition and Anticancer Activity of Echistatin. Toxins (Basel) 2020;12:E709. [PMID: 33182321 DOI: 10.3390/toxins12110709] [Reference Citation Analysis]
149 Lin Z, Goswami N, Xue T, Chai OJH, Xu H, Liu Y, Su Y, Xie J. Engineering Metal Nanoclusters for Targeted Therapeutics: From Targeting Strategies to Therapeutic Applications. Adv Funct Materials 2021;31:2105662. [DOI: 10.1002/adfm.202105662] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
150 Han J, Räder AFB, Reichart F, Aikman B, Wenzel MN, Woods B, Weinmüller M, Ludwig BS, Stürup S, Groothuis GMM, Permentier HP, Bischoff R, Kessler H, Horvatovich P, Casini A. Bioconjugation of Supramolecular Metallacages to Integrin Ligands for Targeted Delivery of Cisplatin. Bioconjugate Chem 2018;29:3856-65. [DOI: 10.1021/acs.bioconjchem.8b00682] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
151 Shao J, Zheng X, Feng L, Lan T, Ding D, Cai Z, Zhu X, Liang R, Wei B. Targeting Fluorescence Imaging of RGD-Modified Indocyanine Green Micelles on Gastric Cancer. Front Bioeng Biotechnol 2020;8:575365. [PMID: 33102459 DOI: 10.3389/fbioe.2020.575365] [Reference Citation Analysis]
152 Kemker I, Schnepel C, Schröder DC, Marion A, Sewald N. Cyclization of RGD Peptides by Suzuki–Miyaura Cross-Coupling. J Med Chem 2019;62:7417-30. [DOI: 10.1021/acs.jmedchem.9b00360] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
153 Chen Y, Li H, Cheng HY, Rui-Qiong M, Ye X, Cui H, Hong-Lan Z, Chang XH. Fibrinogen alpha chain is up-regulated and affects the pathogenesis of endometriosis. Reprod Biomed Online 2019;39:893-904. [PMID: 31740226 DOI: 10.1016/j.rbmo.2019.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
154 Yoo J, Park C, Yi G, Lee D, Koo H. Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems. Cancers (Basel) 2019;11:E640. [PMID: 31072061 DOI: 10.3390/cancers11050640] [Cited by in Crossref: 152] [Cited by in F6Publishing: 112] [Article Influence: 50.7] [Reference Citation Analysis]
155 De Marco R, Rampazzo E, Zhao J, Prodi L, Paolillo M, Picchetti P, Gallo F, Calonghi N, Gentilucci L. Integrin-Targeting Dye-Doped PEG-Shell/Silica-Core Nanoparticles Mimicking the Proapoptotic Smac/DIABLO Protein. Nanomaterials (Basel) 2020;10:E1211. [PMID: 32575872 DOI: 10.3390/nano10061211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Mikulová MB, Mikuš P. Advances in Development of Radiometal Labeled Amino Acid-Based Compounds for Cancer Imaging and Diagnostics. Pharmaceuticals (Basel) 2021;14:167. [PMID: 33669938 DOI: 10.3390/ph14020167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Lilburn DM, Groves AM. The role of PET in imaging of the tumour microenvironment and response to immunotherapy. Clinical Radiology 2021;76:784.e1-784.e15. [DOI: 10.1016/j.crad.2021.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Slack RJ, Macdonald SJF, Roper JA, Jenkins RG, Hatley RJD. Emerging therapeutic opportunities for integrin inhibitors. Nat Rev Drug Discov 2021. [PMID: 34535788 DOI: 10.1038/s41573-021-00284-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Sheikh A, Md S, Kesharwani P. RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy. J Control Release 2021;340:221-42. [PMID: 34757195 DOI: 10.1016/j.jconrel.2021.10.028] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Stoiber D, Assinger A. Platelet-Leukocyte Interplay in Cancer Development and Progression. Cells 2020;9:E855. [PMID: 32244723 DOI: 10.3390/cells9040855] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
161 Dzobo K. Integrins Within the Tumor Microenvironment: Biological Functions, Importance for Molecular Targeting, and Cancer Therapeutics Innovation. OMICS 2021;25:417-30. [PMID: 34191612 DOI: 10.1089/omi.2021.0069] [Reference Citation Analysis]
162 Houshmand M, Garello F, Circosta P, Stefania R, Aime S, Saglio G, Giachino C. Nanocarriers as Magic Bullets in the Treatment of Leukemia. Nanomaterials (Basel) 2020;10:E276. [PMID: 32041219 DOI: 10.3390/nano10020276] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
163 Zheng Y, Lv L, Yi L, Wu R, Xiao R, Wang J. rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice. Molecules 2017;22:E2234. [PMID: 29244724 DOI: 10.3390/molecules22122234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
164 Haider T, Sandha KK, Soni V, Gupta PN. Recent advances in tumor microenvironment associated therapeutic strategies and evaluation models. Materials Science and Engineering: C 2020;116:111229. [DOI: 10.1016/j.msec.2020.111229] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
165 Li J, Chai Z, Lu J, Xie C, Ran D, Wang S, Zhou J, Lu W. ɑvβ3-targeted liposomal drug delivery system with attenuated immunogenicity enabled by linear pentapeptide for glioma therapy. J Control Release 2020;322:542-54. [PMID: 32277962 DOI: 10.1016/j.jconrel.2020.04.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
166 Shen AR, Zhong X, Tang TT, Wang C, Jing J, Liu BC, Lv LL. Integrin, Exosome and Kidney Disease. Front Physiol 2020;11:627800. [PMID: 33569013 DOI: 10.3389/fphys.2020.627800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
167 Borbély A, Figueras E, Martins A, Esposito S, Auciello G, Monteagudo E, Di Marco A, Summa V, Cordella P, Perego R, Kemker I, Frese M, Gallinari P, Steinkühler C, Sewald N. Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery. Pharmaceutics 2019;11:E151. [PMID: 30939768 DOI: 10.3390/pharmaceutics11040151] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
168 Niu L, Zhou H, Lian Y, Gao Y, Liu Y, Gu R, Wu Z, Zhu X, Gan H, Meng Z, Dou G. Evaluation of the metabolism of PEP06, an endostatin-RGDRGD 30-amino-acid polypeptide and a promising novel drug for targeting tumor cells. Journal of Pharmaceutical Analysis 2022. [DOI: 10.1016/j.jpha.2022.03.002] [Reference Citation Analysis]
169 Li F, Zhu Z, Xue M, He W, Zhang T, Feng L, Lin S. siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo. Drug Des Devel Ther 2019;13:757-66. [PMID: 30863015 DOI: 10.2147/DDDT.S180836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
170 Azizi M, Dianat-Moghadam H, Salehi R, Farshbaf M, Iyengar D, Sau S, Iyer AK, Valizadeh H, Mehrmohammadi M, Hamblin MR. Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications. Adv Funct Mater 2020;30:1910402. [PMID: 34093104 DOI: 10.1002/adfm.201910402] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
171 Bognanni N, Viale M, Distefano A, Tosto R, Bertola N, Loiacono F, Ponassi M, Spinelli D, Pappalardo G, Vecchio G. Cyclodextrin Polymers as Delivery Systems for Targeted Anti-Cancer Chemotherapy. Molecules 2021;26:6046. [PMID: 34641590 DOI: 10.3390/molecules26196046] [Reference Citation Analysis]
172 Salahpour anarjan F. Active targeting drug delivery nanocarriers: Ligands. Nano-Structures & Nano-Objects 2019;19:100370. [DOI: 10.1016/j.nanoso.2019.100370] [Cited by in Crossref: 25] [Cited by in F6Publishing: 2] [Article Influence: 8.3] [Reference Citation Analysis]
173 Al Faruque H, Choi ES, Kim JH, Kim E. Enhanced effect of autologous EVs delivering paclitaxel in pancreatic cancer. J Control Release 2022;347:330-46. [PMID: 35561870 DOI: 10.1016/j.jconrel.2022.05.012] [Reference Citation Analysis]
174 Aliouat H, Peng Y, Waseem Z, Wang S, Zhou W. Pure DNA scaffolded drug delivery systems for cancer therapy. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121532] [Reference Citation Analysis]
175 Sanmukh SG, Santos NJ, Barquilha CN, Dos Santos SAA, Duran BOS, Delella FK, Moroz A, Justulin LA, Carvalho HF, Felisbino SL. Exposure to Bacteriophages T4 and M13 Increases Integrin Gene Expression and Impairs Migration of Human PC-3 Prostate Cancer Cells. Antibiotics (Basel) 2021;10:1202. [PMID: 34680783 DOI: 10.3390/antibiotics10101202] [Reference Citation Analysis]
176 Höltke C, Alsibai W, Grewer M, Stölting M, Geyer C, Eisenblätter M, Wildgruber M, Helfen A. How Different Albumin-Binders Drive Probe Distribution of Fluorescent RGD Mimetics. Front Chem 2021;9:689850. [PMID: 34504831 DOI: 10.3389/fchem.2021.689850] [Reference Citation Analysis]
177 Räder AFB, Weinmüller M, Reichart F, Schumacher-klinger A, Merzbach S, Gilon C, Hoffman A, Kessler H. Oral aktive Peptide: Gibt es ein Patentrezept? Angew Chem 2018;130:14614-40. [DOI: 10.1002/ange.201807298] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
178 Weinmüller M, Rechenmacher F, Kiran Marelli U, Reichart F, Kapp TG, Räder AFB, Di Leva FS, Marinelli L, Novellino E, Muñoz-Félix JM, Hodivala-Dilke K, Schumacher A, Fanous J, Gilon C, Hoffman A, Kessler H. Overcoming the Lack of Oral Availability of Cyclic Hexapeptides: Design of a Selective and Orally Available Ligand for the Integrin αvβ3. Angew Chem Int Ed Engl 2017;56:16405-9. [PMID: 29072809 DOI: 10.1002/anie.201709709] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
179 Pokharel SM, Shil NK, Gc JB, Colburn ZT, Tsai SY, Segovia JA, Chang TH, Bandyopadhyay S, Natesan S, Jones JCR, Bose S. Integrin activation by the lipid molecule 25-hydroxycholesterol induces a proinflammatory response. Nat Commun 2019;10:1482. [PMID: 30931941 DOI: 10.1038/s41467-019-09453-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
180 Maggi V, Bianchini F, Portioli E, Peppicelli S, Lulli M, Bani D, Del Sole R, Zanardi F, Sartori A, Fiammengo R. Gold Nanoparticles Functionalized with RGD‐Semipeptides: A Simple yet Highly Effective Targeting System for α V β 3 Integrins. Chem Eur J 2018;24:12093-100. [DOI: 10.1002/chem.201801823] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
181 Díaz Flaqué MC, Cayrol MF, Sterle HA, Del Rosario Aschero M, Díaz Albuja JA, Isse B, Farías RN, Cerchietti L, Rosemblit C, Cremaschi GA. Thyroid hormones induce doxorubicin chemosensitivity through enzymes involved in chemotherapy metabolism in lymphoma T cells. Oncotarget 2019;10:3051-65. [PMID: 31105885 DOI: 10.18632/oncotarget.26890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
182 Alday-Parejo B, Stupp R, Rüegg C. Are Integrins Still Practicable Targets for Anti-Cancer Therapy?Cancers (Basel). 2019;11. [PMID: 31336983 DOI: 10.3390/cancers11070978] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 18.3] [Reference Citation Analysis]
183 Sheikh A, Alhakamy NA, Md S, Kesharwani P. Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer. Front Pharmacol 2022;12:803304. [DOI: 10.3389/fphar.2021.803304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
184 Bieri M, Hendrickx R, Bauer M, Yu B, Jetzer T, Dreier B, Mittl PRE, Sobek J, Plückthun A, Greber UF, Hemmi S. The RGD-binding integrins αvβ6 and αvβ8 are receptors for mouse adenovirus-1 and -3 infection. PLoS Pathog 2021;17:e1010083. [PMID: 34910784 DOI: 10.1371/journal.ppat.1010083] [Reference Citation Analysis]
185 Singh MK, Lakshman MK. Recent developments in the utility of saturated azaheterocycles in peptidomimetics. Org Biomol Chem 2022;20:963-79. [PMID: 35018952 DOI: 10.1039/d1ob01329g] [Reference Citation Analysis]
186 Balion Z, Sipailaite E, Stasyte G, Vailionyte A, Mazetyte-Godiene A, Seskeviciute I, Bernotiene R, Phopase J, Jekabsone A. Investigation of Cancer Cell Migration and Proliferation on Synthetic Extracellular Matrix Peptide Hydrogels. Front Bioeng Biotechnol 2020;8:773. [PMID: 33014989 DOI: 10.3389/fbioe.2020.00773] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
187 David V, Succar BB, de Moraes JA, Saldanha-Gama RFG, Barja-Fidalgo C, Zingali RB. Recombinant and Chimeric Disintegrins in Preclinical Research. Toxins (Basel) 2018;10:E321. [PMID: 30087285 DOI: 10.3390/toxins10080321] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
188 Brennecke B, Wang Q, Haap W, Grether U, Hu HY, Nazaré M. DOTAM-Based, Targeted, Activatable Fluorescent Probes for the Highly Sensitive and Selective Detection of Cancer Cells. Bioconjug Chem 2021;32:702-12. [PMID: 33691062 DOI: 10.1021/acs.bioconjchem.0c00699] [Reference Citation Analysis]
189 Isal S, Pierson J, Imbert L, Clement A, Collet C, Pinel S, Veran N, Reinhard A, Poussier S, Gauchotte G, Frezier S, Karcher G, Marie PY, Maskali F. PET imaging of 68Ga-NODAGA-RGD, as compared with 18F-fluorodeoxyglucose, in experimental rodent models of engrafted glioblastoma. EJNMMI Res 2018;8:51. [PMID: 29904818 DOI: 10.1186/s13550-018-0405-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
190 Weinmüller M, Rechenmacher F, Kiran marelli U, Reichart F, Kapp TG, Räder AFB, Di leva FS, Marinelli L, Novellino E, Muñoz-félix JM, Hodivala-dilke K, Schumacher A, Fanous J, Gilon C, Hoffman A, Kessler H. Lösung des Problems mangelnder oraler Verfügbarkeit cyclischer Hexapeptide: Entwicklung eines selektiven, oral verfügbaren Liganden für das Integrin αvβ3. Angew Chem 2017;129:16624-9. [DOI: 10.1002/ange.201709709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
191 Pirooznia N, Abdi K, Beiki D, Emami F, Arab SS, Sabzevari O, Pakdin-Parizi Z, Geramifar P. Radiosynthesis, Biological Evaluation, and Preclinical Study of a 68Ga-Labeled Cyclic RGD Peptide as an Early Diagnostic Agent for Overexpressed α v β 3 Integrin Receptors in Non-Small-Cell Lung Cancer. Contrast Media Mol Imaging 2020;2020:8421657. [PMID: 32292304 DOI: 10.1155/2020/8421657] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
192 Pearson GW. Control of Invasion by Epithelial-to-Mesenchymal Transition Programs during Metastasis. J Clin Med. 2019;8. [PMID: 31083398 DOI: 10.3390/jcm8050646] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 18.7] [Reference Citation Analysis]